Clinical Gastroenterology and Hepatology

Article	Citations
Information for Authors and Readers	342
Reply	314
Reply	274
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	236
Visualization of Buried Bumper Syndrome With Upper Endoscopy	191
Seeking Health Care During COVID-19	165
Stratifying the Risk of IPMNs: Don’t Rule Out the EUS Toolkit	162
Reply	159
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	156
Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women	148
Inverse Association Between Fatty Liver at Baseline Ultrasonography and Remission of Type 2 Diabetes Over a 2-Year Follow-up Period	139
Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children	137
Functional Abdominal Pain Disorders and Constipation in Children on Gluten-Free Diet	123
Interplay Between Dyslipidemia, Atherogenic Lipoproteins, and Residual Atherogenic Risk in Liver Transplant Recipients	121
Rates of Bleeding and Discontinuation of Direct Oral Anticoagulants in Patients With Decompensated Cirrhosis	118
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	117
A High-Risk Subpopulation in the United States Disproportionately Affected by High Rates of Gastric Cancer: The Alaska Native People	115
Reply	111
Cover	111
One Year of Gluten-Free Diet Impacts Gut Function and Microbiome in Celiac Disease	108
Inadequate Efficacy of Biologics for Treating Proximal Ileal Lesions in Crohn’s Disease; A Prospective Multicenter Study	107
Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021	103
An Elusive Pancreatic Mass	100
Prevalence and Prognosis of Mild Inflammatory Bowel Disease: A Population-based Cohort Study, 1997–2020	100
Hepatic Artery Pseudoaneurysm After Whipple Procedure	96

Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility	92
Prediction and Prevention of Inflammatory Bowel Disease	92
Editorial Board	91
Outcomes of Long-term Tumor Necrosis Factor Alpha Inhibitor Therapy Beyond 10 Years in Inflammatory Bowel Disease	91
Opening a Can of Worms: A Case of Strongyloidiasis Diagnosed by Colonoscopy	87
Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B	85
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	83
Reply on “Tenofovir is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus-related Hepatocellular Carcinoma”	81
FODMAPs in IBS: Revisiting Restriction	80
Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod	78
SARS-CoV-2-Induced Pancreatitis is a Rare but Real Entity	77
Diagnosis of Preclinical Crohn’s Disease: Hurdles, Challenges, and Hopes	77
Editorial Board	72
Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis	72
Blue Notes	72
Knot a Typical Clogged Jejunostomy Tube	71
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion	71
Editorial Board	71
May Computed Tomography Scan as First-Line Investigation Reduce the Overuse of Colonoscopy in Post-Polypectomy Bleeding?	69
Cover	68
Exam 2: Ultra-processed Foods and Risk of Crohn’s Disease and Ulcerative Colitis: A Prospective Cohort Study	68
Achieving Virological Response in Patients With Hepatitis C Is Only Half Way for Effective Care	68
Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis	67
Association Between Provider Connectedness and Inflammatory Bowel Disease Outcomes	67
Attribution of Colonoscopy Risk Does Not FIT!	67
Issue Highlights	66
Endoscopy Training in the Age of Artificial Intelligence: Deep Learning or Artificial Competence?	66
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	66
Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial	66
High Prevalence of Osteopathy in Chronic Pancreatitis: A Cross-sectional Analysis From the PROCEED Study	66
A Model Using Clinical and Endoscopic Characteristics Identifies Patients at Risk for Eosinophilic Esophagitis According to Updated Diagnostic Guidelines	65
Cover	65
Surgery for Strangulated Gastric Volvulus Should Not Be Delayed	64
Incidental Finding of Lymphocytic Gastritis After an Upper Gastrointestinal Bleed	64
Leveraging Social Media to Enhance Recruitment Efforts in Fellowship Training Programs	62
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis	61
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults	60
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease	60
Table of Contents	59
Sex-separated NAFLD/NASH Scores May Improve Predictive Performance	59
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	59
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	59
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	59
Metabolically Healthy Obese MAFLD: Are They Truly Healthy?	59
Reply	58
Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?	58
Reply	58
Exam 1: Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis	57
A Revisit of the Natural History of Nonalcoholic Fatty Liver Disease	57
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	56

The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	56
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	56
Exam 1: Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis	55
Editorial Board	55
Cover	55
Histology, Size, and Number of Advanced Polyps are Associated With Guideline-Discordant Surveillance Recommendations	54
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	53
Reply	53
Contents	52
Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis	52
Reply	52
A Small Esophageal Adenoid Cystic Carcinoma Treated by Endoscopic Submucosal Dissection	52
Reply	52
Reply	52
Reply	52
An Unexpected Case of Right Iliac Fossa Pain: Amyand Hernia	51
A Rare Cause of Sister Mary Joseph Nodule	51
Predicting the Development of Chronic Cholecystitis: Does It Matter?	51
Exam 1: Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease	50
Exam 1: What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis	50
Editorial Board	50
Reply	49
Cover	49
Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis	49
Performance and Predictors of Migration of Partially and Fully Covered Esophageal Self-Expanding Metal Stents for Malignant Dysphagia	49
A Giant Trichobezoar Diagnosed by Ultrasound, Confirmed by Upper Endoscopy, and Managed by Minimally Invasive Laparoscopic Surgery	49
Exam 2: Risks, Benefits, and Effects on Management for Biopsy of the Papilla in Patients With Familial Adenomatous Polyposis	48
Reply	48
Exam 2: Factors Associated with Inpatient Endoscopy Delay and Its Impact on Hospital Length-of-Stay and 30-Day Readmission	48
Elsewhere in the AGA Journals	47
Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti–Tumor Necrosis Factor Therapy	47
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study	47
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening	47
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study	47
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease	47
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson’s Disease	46
Outcomes Related to Mucosal Healing in Patients With Crohn's Disease	46
Lessons Learned From Two Prematurely Terminated, Randomized Trials on Biliary Drainage in Perihilar Cholangiocarcinoma	46
Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis	45
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)	45
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!	45
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas	45
Reply	44
Determinants and Trends of Adherence to a Gluten-Free Diet in Adult Celiac Patients on a Long-term Follow-up (2000–2020)	44
The Surface Morphology of Large Nonpedunculated Colonic Polyps Predicts Synchronous Large Lesions	44
Reply	44
An Automated Reporting System for Colonoscopy Quality: Lessons in Implementation	44
Decompensation in Patients With Advanced NAFLD: More Questions That Need Answering	44
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	44
Editorial Board	43
QuickStroop, a Shortened Version of EncephalApp, Detects Covert Hepatic Encephalopathy With Similar Accuracy Within One Minute	43
An Unusual Encounter in the Rectum	43
Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death	43
Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT	42
Elsewhere in the AGA Journals	42
Cover	42
The Clue Is in the Stool	41
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	41
Issue Highlights	41
Cover	41
Editorial Board	41
Blue Notes	41
Risk of Late Postoperative Recurrence of Crohn’s Disease in Patients in Endoscopic Remission After Ileocecal Resection, Over 10 Years at Multiple Centers	40
Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists	40
Editorial Board	40
Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease	40
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study	40
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis	40
Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia	40
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis	40
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	40
Scrutinizing ChatGPT Applications in Gastroenterology: A Call for Methodological Rigor to Define Accuracy and Preserve Privacy	39
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	39
Follow-Up Colonoscopy for Detection of Missed Colorectal Cancer After Diverticulitis	39
Table of Contents	39
Assessment and Significance of Histologic Activity in Crohn’s Disease	39
Reply	39
Artificial Intelligence Chatbots in Healthcare: Navigating Accuracy, Privacy, and Global Applicability	39
Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population	38
GALAD Score for HCC Screening and Surveillance	38

Stercoral Colitis in an Adolescent	38
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in Patients With Alcoholic Hepatitis	38
Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett’s Esophagus Surveillance After Endoscopic Therapy	38
Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease	37
Efficacy of Mesalamine in Irritable Bowel Syndrome	37
The “Bubble Sign” Indicating Ileal Pneumatosis Cystoides	36
Response to: Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlate With Rate of Infection	36
Near-Complete Disappearance of a Giant Focal Nodular Hyperplasia in the Liver	36
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis	36
Cover	36
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details	36
Reply	35
Defining the Long-Term Clinical Course and Need for Repeat Dilation for Patients With Schatzki Rings	35
Esophageal Angiolipoma: A Tongue-Like Mucosal Mass	35
Endoscopic Diverticular Ridge Myotomy to Treat Acute Colonic Diverticulitis Caused by Impacted Fecalith	35
Management of Gastrointestinal Side Effects of Immune Checkpoint Inhibitors	35
Elsewhere in the AGA Journals	35
Immunomodulator Withdrawal From Anti-TNF Therapy Needs a Careful Patient Selection	35
Reply	35
Panpancreatic Infiltration and Painless Jaundice in HIV/AIDS	35
Editorial Board	35
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	34
Assessment of Change in Polymorphs Ascitic Fluid in Spontaneous Bacterial Peritonitis: Need for an “a la Carte” Approach	34
Table of Contents	34
Blue Notes	34
Editorial Board	34
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage	34
Table of Contents	34
Successful Endoscopic Closure of Gastrobronchial Fistula Using Polyglycolic Acid Sheets with Fibrin Glue	33
Elsewhere in the AGA Journals	33
Blue Notes	33
Blue Notes	33
Over-the-Scope Clip in the Management of Nonvariceal UGI Bleeding	33
Front Cover	33
Reply	32
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	32
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine	32
Table of Contents	32
The Efficacy of Real-time Computer-aided Detection of Colonic Neoplasia in Community Practice: A Pragmatic Randomized Controlled Trial	32
Emergency Department Utilization and Outcomes Among Adults With Cirrhosis From 2008 to 2022 in the United States	32
Editorial Board	32
Hereditary Angioedema: A Rare Cause of Acute Pancreatitis	32
Appendectomy and Future Risk of Microscopic Colitis: A Population-Based Case-Control Study in Sweden	32
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn’s Disease	32
A Practical Approach to Navigating Relevance, Regulatory, and Reimbursement in Gastroenterology Innovation for Gastroenterology Trainees	32
Update in the Treatment of the Complications of Cirrhosis	32
Reply	32
Validation of a National Pathology Database for Colonoscopy Quality Reporting and Assurance	32
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	32
Can Subcutaneous Infliximab Replace Dose-Intensified Intravenous Administration in Inflammatory Bowel Disease?	31
A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients	31
AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review	31
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy	31
The Discrepant Visual Representation of Inflammatory Bowel Diseases in the Internet and Media	31
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	31
Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection	31
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care	31
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	31
Reply	31
Asymptomatic Colonic Perforation Caused by PEG Tube Placement	30
Reply	30
Big Data on Gastric Dysplasia Support Gastric Cancer Prevention	30
Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome	30
Meet EBE: The Development of an Evidence-Based Endoscopy Simulator	30
Prevalence and Characteristics of Abdominal Pain in the United States	30
A Trial of Ornithine Phenylacetate and the Arc of Ammonia’s History in the Management of Overt Hepatic Encephalopathy	30
High Use of Estrogen-based Contraceptives in Young Women With Inflammatory Bowel Disease in the United States	29
Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go	29
A Rare Case of Esophageal Granular Cell Tumor in Eosinophilic Esophagitis	29
Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection	29
Prevalence and Predictors of Barrett’s Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases	29
Killian Jamieson Diverticulum: A Rare Presentation With Food Impaction	29
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	29
Reply	29
Predicting Need for Aggressive Endoscopic Therapy After Endoscopic Ultrasound–Guided Drainage of Pancreatic Fluid Collections With Lumen Apposing Metal Stents	29
Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States	29
Blue Notes	29
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	29
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	29
Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?	29
Editorial Board	29
Frequency of Bowel Movements and Risk of Diverticulitis	28
Superiority of Self-Expandable Metallic Stents Over Plastic Stents in Treatment of Malignant Distal Biliary Strictures	28
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients	28
A Conceptual Model for Implementation and Evaluation of Interventions Across the Hepatocellular Carcinoma Care Continuum	28
A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study	28
High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets	28
Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease	28
Prediction of Progression in Barrett’s Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies	28
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer	28
TIPS in Patients With Hepatocellular Carcinoma: Is There an Indication?	28
Gluten Intake and Risk of Digestive System Cancers in 3 Large Prospective Cohort Studies	28
Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States	27
Patients’ Risk Tolerance for Non-Dietary Therapies in Celiac Disease	27
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis	27